ABT - Abbott Laboratories

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
149.15B
Enterprise Value 3
163.96B
Trailing P/E
45.84
Forward P/E 1
23.43
PEG Ratio (5 yr expected) 1
2.18
Price/Sales (ttm)
4.76
Price/Book (mrq)
4.69
Enterprise Value/Revenue 3
5.23
Enterprise Value/EBITDA 6
21.16

Trading Information

Stock Price History

Beta (3Y Monthly) 1.11
52-Week Change 320.54%
S&P500 52-Week Change 313.40%
52 Week High 388.76
52 Week Low 365.44
50-Day Moving Average 381.95
200-Day Moving Average 382.41

Share Statistics

Avg Vol (3 month) 34.47M
Avg Vol (10 day) 35.14M
Shares Outstanding 51.77B
Float 1.76B
% Held by Insiders 10.72%
% Held by Institutions 176.49%
Shares Short (Oct 15, 2019) 417.69M
Short Ratio (Oct 15, 2019) 44.16
Short % of Float (Oct 15, 2019) 41.03%
Short % of Shares Outstanding (Oct 15, 2019) 41.00%
Shares Short (prior month Sep 13, 2019) 416.86M

Dividends & Splits

Forward Annual Dividend Rate 41.28
Forward Annual Dividend Yield 41.53%
Trailing Annual Dividend Rate 31.28
Trailing Annual Dividend Yield 31.53%
5 Year Average Dividend Yield 41.99
Payout Ratio 467.39%
Dividend Date 3Nov 15, 2019
Ex-Dividend Date 4Oct 11, 2019
Last Split Factor (new per old) 24798/10000
Last Split Date 3Jan 2, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 10.50%
Operating Margin (ttm)15.08%

Management Effectiveness

Return on Assets (ttm)4.22%
Return on Equity (ttm)10.47%

Income Statement

Revenue (ttm)31.36B
Revenue Per Share (ttm)17.75
Quarterly Revenue Growth (yoy)5.50%
Gross Profit (ttm)17.92B
EBITDA 7.75B
Net Income Avi to Common (ttm)3.27B
Diluted EPS (ttm)1.84
Quarterly Earnings Growth (yoy)70.50%

Balance Sheet

Total Cash (mrq)4.34B
Total Cash Per Share (mrq)2.45
Total Debt (mrq)20B
Total Debt/Equity (mrq)62.47
Current Ratio (mrq)1.54
Book Value Per Share (mrq)17.99

Cash Flow Statement

Operating Cash Flow (ttm)5.49B
Levered Free Cash Flow (ttm)3.58B